Synthace Named a 2018 Cool Vendor in Life Sciences by Gartner

Synthace

Recognised by Leading Analyst Firm for its Laboratory of the Future Platform

LONDON 19 June 2018 – Synthace Ltd., the company behind the leading cloud software platform for automating and improving the success rate of biological research and development, today announced it has been recognised in Gartner Inc.’s “Cool Vendors in Life Sciences” report published on June 6, 2018. The companies named in this report represent a look into the new and innovative vendors, products and services in the global Life Sciences market.

Gartner’s report points out, “Big data and advanced analytics solutions deployed in the cloud are now available to increase supply chain resiliency and design, and execute and analyze biological workflows.”

“We are delighted to be named a 2018 Gartner Cool Vendor in Life Sciences” said Tim Fell, CEO Synthace. “We believe this achievement testifies to Synthace’s success in empowering CIOs who are interested in building their laboratory of the future”. Fell concluded, “We are at the forefront of a seismic change in the biotechnology sector. The problem, and the opportunity, is how to work with ever increasing biological complexity. Better computer-aided biology is key and an area in which Synthace excels.”

Gartner Disclaimer

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Gartner clients can access the report here https://www.gartner.com/doc/3877569/cool-vendors-life-sciences.

To learn more, browse the Synthace website: https://synthace.com/introducing-antha

More News

UKI2S announces seed investment in Cagen, a pioneering synthetic biology...

UK Innovation & Science Seed Fund (UKI2S) and Imperial Innovations announce the launch of...

read more

Scientists scramble to stop bananas being killed off

Banana plantations in Australia, south-east Asia, Africa and the Middle East have been ravaged...

read more